Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Daily 0.3 mg Dose	7
Overall Study	STARTED	Daily 1 mg Dose	42
Overall Study	STARTED	Daily 3 mg Dose	55
Overall Study	STARTED	Placebo	56
Overall Study	COMPLETED	Daily 0.3 mg Dose	7
Overall Study	COMPLETED	Daily 1 mg Dose	37
Overall Study	COMPLETED	Daily 3 mg Dose	44
Overall Study	COMPLETED	Placebo	49
Overall Study	NOT COMPLETED	Daily 0.3 mg Dose	0
Overall Study	NOT COMPLETED	Daily 1 mg Dose	5
Overall Study	NOT COMPLETED	Daily 3 mg Dose	11
Overall Study	NOT COMPLETED	Placebo	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04210245/flow